Erasca Inc. Common Stock vs Nvidia Corp — how do they compare? Erasca Inc. Common Stock trades at $15.87 (market cap $5.40B), while Nvidia Corp trades at $229.63 (market cap $5.57T). The key difference: Nvidia Corp is far larger — about 1031.5× Erasca Inc. Common Stock's market cap, and Nvidia Corp pays a 0.43% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Nvidia Corp for 115 Days on average.
| ERAS | NVDA | |
|---|---|---|
Market Cap | $5.40B | $5.57T |
Volume | 9,533,185 | 117,720,595 |
Sector | Health | Technology |
52-Week High | $22.47 | $239.27 |
52-Week Low | $2.20 | $165.17 |
Typical Hold Time | 0 Days | 115 Days |
Enterprise Value | $5.18B | $5.54T |
Dividend Yield | — | 0.43% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVIDIA (NVDA) trades at $229.25, down 3.42% over the past day amid a broader tech sell-off. The stock maintains a bullish technical signal with strong support near $228 and resistance at $235. Fundamentally, the company reported record revenue of $130.50B in 2025, with net income surging to $72.88B, reflecting a 55.84% profit margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.22 surpassing the $2.09 estimate. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $339.17 implying significant upside.
NVDA's outlook is supported by robust AI chip demand and accelerating revenue growth, projected to reach $303.0B in 2026. However, risks include heightened competition, potential peak AI spending, and geopolitical tensions affecting market sentiment. The stock presents a compelling growth opportunity but requires monitoring of execution risks and macroeconomic headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →